Biogen, Ionis shares rally as muscle drug for infants hits its goal

Biogen, Ionis shares rally as muscle drug for infants hits its goal

Biogen and Ionis Pharmaceuticals shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.